These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17569088)

  • 1. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.
    Arning L; Saft C; Wieczorek S; Andrich J; Kraus PH; Epplen JT
    Hum Genet; 2007 Sep; 122(2):175-82. PubMed ID: 17569088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.
    Arning L; Kraus PH; Valentin S; Saft C; Andrich J; Epplen JT
    Neurogenetics; 2005 Feb; 6(1):25-8. PubMed ID: 15742215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
    Andresen JM; Gayán J; Cherny SS; Brocklebank D; Alkorta-Aranburu G; Addis EA; ; Cardon LR; Housman DE; Wexler NS
    J Med Genet; 2007 Jan; 44(1):44-50. PubMed ID: 17018562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.
    Valcárcel-Ocete L; Alkorta-Aranburu G; Iriondo M; Fullaondo A; García-Barcina M; Fernández-García JM; Lezcano-García E; Losada-Domingo JM; Ruiz-Ojeda J; Álvarez de Arcaya A; Pérez-Ramos JM; Roos RA; Nielsen JE; Saft C; ; Zubiaga AM; Aguirre A
    PLoS One; 2015; 10(7):e0131573. PubMed ID: 26148071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNR1 variation is associated with the age at onset in Huntington disease.
    Kloster E; Saft C; Epplen JT; Arning L
    Eur J Med Genet; 2013 Aug; 56(8):416-9. PubMed ID: 23747361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.
    Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL
    J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.
    Arning L; Monté D; Hansen W; Wieczorek S; Jagiello P; Akkad DA; Andrich J; Kraus PH; Saft C; Epplen JT
    J Mol Med (Berl); 2008 Apr; 86(4):485-90. PubMed ID: 18327563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor gene variations as modifiers in Huntington disease: a replication study.
    Saft C; Epplen JT; Wieczorek S; Landwehrmeyer GB; Roos RA; de Yebenes JG; Dose M; Tabrizi SJ; Craufurd D; ; Arning L
    PLoS Curr; 2011 Oct; 3():RRN1247. PubMed ID: 21989477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
    Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP
    Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset.
    Ramos EM; Latourelle JC; Gillis T; Mysore JS; Squitieri F; Di Pardo A; Di Donato S; Gellera C; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Abramson RK; Marder K; Gusella JF; Lee JM; Alonso I; Sequeiros J; Myers RH; Macdonald ME
    Neurogenetics; 2013 Nov; 14(3-4):173-9. PubMed ID: 23644918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.
    Kloster E; Saft C; Akkad DA; Epplen JT; Arning L
    J Mol Med (Berl); 2014 Feb; 92(2):177-84. PubMed ID: 24121255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.
    Mai M; Akkad AD; Wieczorek S; Saft C; Andrich J; Kraus PH; Epplen JT; Arning L
    BMC Med Genet; 2006 Nov; 7():79. PubMed ID: 17096834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
    Djoussé L; Knowlton B; Hayden MR; Almqvist EW; Brinkman RR; Ross CA; Margolis RL; Rosenblatt A; Durr A; Dode C; Morrison PJ; Novelletto A; Frontali M; Trent RJ; McCusker E; Gómez-Tortosa E; Mayo Cabrero D; Jones R; Zanko A; Nance M; Abramson RK; Suchowersky O; Paulsen JS; Harrison MB; Yang Q; Cupples LA; Mysore J; Gusella JF; MacDonald ME; Myers RH
    Neurogenetics; 2004 Jun; 5(2):109-14. PubMed ID: 15029481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD).
    Arning L; Kraus PH; Saft C; Andrich J; Epplen JT
    BMC Med Genet; 2005 Oct; 6():35. PubMed ID: 16202123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of variations in the glutamate receptor, N-methyl D-aspartate 2A (GRIN2A) gene reveals their relative importance as genetic susceptibility factors for heroin addiction.
    Zhao B; Zhu Y; Wang W; Cui HM; Wang YP; Lai JH
    PLoS One; 2013; 8(8):e70817. PubMed ID: 23940648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease.
    Tsai SJ; Liu HC; Liu TY; Cheng CY; Hong CJ
    J Neural Transm (Vienna); 2002 Apr; 109(4):483-8. PubMed ID: 11956967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.
    Hansen W; Saft C; Andrich J; Müller T; Wieczorek S; Epplen JT; Arning L
    J Negat Results Biomed; 2005 Dec; 4():12. PubMed ID: 16372906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.
    Ramos EM; Latourelle JC; Lee JH; Gillis T; Mysore JS; Squitieri F; Di Pardo A; Di Donato S; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Marder K; Gusella JF; Lee JM; Alonso I; Sequeiros J; Myers RH; Macdonald ME
    Hum Genet; 2012 Dec; 131(12):1833-40. PubMed ID: 22825315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia.
    Itokawa M; Yamada K; Yoshitsugu K; Toyota T; Suga T; Ohba H; Watanabe A; Hattori E; Shimizu H; Kumakura T; Ebihara M; Meerabux JM; Toru M; Yoshikawa T
    Pharmacogenetics; 2003 May; 13(5):271-8. PubMed ID: 12724619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients.
    Tsai YC; Metzger S; Riess O; Soehn AS; Nguyen HP
    BMC Med Genet; 2012 Jun; 13():48. PubMed ID: 22720673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.